Related references
Note: Only part of the references are listed.Imatinib melylate as second-line treatment of bronchiolitis obliterans after allogenic hematopoietic stem cell transplantation in children
Maura Faraci et al.
PEDIATRIC PULMONOLOGY (2020)
Modulation of NLRP3 Inflammasome through Formyl Peptide Receptor 1 (Fpr-1) Pathway as a New Therapeutic Target in Bronchiolitis Obliterans Syndrome
Ramona D'Amico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis
Veronica Codullo et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Hyaluronic Acid-Decorated Liposomes as Innovative Targeted Delivery System for Lung Fibrotic Cells
Laura Pandolfi et al.
MOLECULES (2019)
Thirty Years of Cancer Nanomedicine: Success, Frustration, and Hope
Lucia Salvioni et al.
CANCERS (2019)
Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush
Enrico Gugliandolo et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Aerosol Delivery of Functionalized Gold Nanoparticles Target and Activate Dendritic Cells in a 3D Lung Cellular Model
Kleanthis Fytianos et al.
ACS NANO (2017)
The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans
Chong Zhang et al.
JOURNAL OF CARDIOTHORACIC SURGERY (2017)
Imatinib ameliorates bronchiolitis obliterans via inhibition of fibrocyte migration and differentiation
Satoshi Watanabe et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2017)
Bioengineered gold nanoparticles targeted to mesenchymal cells from patients with bronchiolitis obliterans syndrome does not rise the inflammatory response and can be safely inhaled by rodents
Emanuela Cova et al.
NANOTOXICOLOGY (2017)
Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection
Deepak K. Nayak et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Pathophysiology and classification of primary graft dysfunction after lung transplantation
Morvern Isabel Morrison et al.
JOURNAL OF THORACIC DISEASE (2017)
The Role of TGF- in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome
A. DerHovanessian et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction
Emanuela Cova et al.
NANOMEDICINE (2015)
Nanoparticle-Mediated Pulmonary Drug Delivery: A Review
Mukta Paranjpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples
Frency Varghese et al.
PLOS ONE (2014)
Mast cells in a murine lung ischemia-reperfusion model of primary graft dysfunction
John R. Greenland et al.
RESPIRATORY RESEARCH (2014)
Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
Aaron C. Anselmo et al.
ACS NANO (2013)
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
Attilio Olivieri et al.
BLOOD (2013)
Aerosol Delivery of Nanoparticles in Uniform Mannitol Carriers Formulated by Ultrasonic Spray Freeze Drying
Suzanne M. D'Addio et al.
PHARMACEUTICAL RESEARCH (2013)
Orthotopic and heterotopic tracheal transplantation model in studying obliterative bronchiolitis
Kai Fan et al.
TRANSPLANT IMMUNOLOGY (2013)
Chronic Rejection Pathology after Orthotopic Lung Transplantation in Mice: The Development of a Murine BOS Model and Its Drawbacks
Stephanie De Vleeschauwer et al.
PLOS ONE (2012)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapies
J. H. W. Distler et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Nanodelivery in airway diseases: Challenges and therapeutic applications
Indrajit Roy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Posttransplant Bronchiolitis Obliterans Syndrome Is Associated with Bronchial Epithelial to Mesenchymal Transition
S. Hodge et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Translational Research: Animal Models of Obliterative Bronchiolitis after Lung Transplantation
M. Sato et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
Attilio Olivieri et al.
BLOOD (2009)
The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis
DJ Hele et al.
RESPIRATORY RESEARCH (2001)
Share Paper
